News | August 08, 2022
Valiant Organics to start production of OAP and Pharma Intermediates
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
he US FDA has issued six observations pursuant to the completion of the audit.
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
Subscribe To Our Newsletter & Stay Updated
